BSTK yields 15384.62% · JNJ yields 2.13%● Live data
📍 BSTK pulled ahead of the other in Year 1
Combined, BSTK + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BSTK + JNJ for your $10,000?
Brite-Strike Tactical Illumination Products, Inc. designs and manufactures tactical lighting products and solutions for the military, law enforcement, hunting, camping, outdoor recreation, and marine safety markets in the United States. The company provides Tactical Blue Dot series products, perimeter infrared intrusion security alert products, adhesive light strips, remote pressure switches, rolling illuminated distraction and disorientation devices, baton integrated lights, duty light cameras, basic tactical lights, observation cameras, police cycle and traffic safety gloves, executive precision lighting instruments, and helmet light attachment systems, as well as accessories, such as holsters, color lenses, and batteries. It also offers outdoor adventure and recreation products, including rechargeable lighted dog collars and leashes, adhesive light strips, outdoor adventure signal safety packs, camp alert perimeter security and survival signaling systems, and sport gloves; and citizens safety products comprising personal protection systems, personal alarms, and anodized aluminum LED multi-tools, as well as tactical flashlight instructor courses. The company is based in Plymouth, Massachusetts.
Full BSTK Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.